Switchable with visible light cisplatin analogs and complexes of selected transition metals - photochemical and anticancer activity in vitro

2021/41/B/NZ7/02484

Keywords

Descriptors

  • ST4_012: Fotochemia
  • ST4_011: Chemia koordynacyjna, supramolekularna
  • NZ7_014: Farmacja, farmakoterapia, farmakologia

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Uniwersytet Jagielloński, Wydział Chemii

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

prof. Krzysztof Szczubiałka

Number of co-investigators in the project: 6

Call

OPUS 21 – announced on 2021-03-15

Amount awarded
1 655 646 PLN
Project start date
2022-04-01
Project end date
2027-03-31
Project duration
60 months (the same as in the proposal)
Project status
Pending project

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (1)

  1. Light-Controlled Anticancer Activity and Cellular Uptake of a Photoswitchable Cisplatin Analogue

    Authors:
    Marta Stolarek, Kamil Kaminski, Marta Kaczor-Kamińska, Magdalena Obłoza, Piotr Bonarek, Anna Czaja, Magdalena Datta, Wojciech Łach, Mateusz Brela, Artur Sikorski, Janusz Rak, Maria Nowakowska, Krzysztof Szczubiałka*
    Academic press:
    Journal of Medicinal Chemistry (year: 2024, volume: 67, pages: 19103-19120), Publisher: American Chemical Society
    Status:
    Published
    DOI:
    10.1021/acs.jmedchem.4c01575 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski